Microbiota composition-based donor selection affects FMT efficacy in a murine colitis model
BackgroundGrowing evidence links gut microbial dysbiosis to inflammatory bowel disease (IBD) pathogenesis, establishing fecal microbiota transplantation (FMT) as a microbiota-targeted therapy; however, variable outcomes in randomized trials highlight t…